65%Confidence
0Views
SEC EDGARSource
2026-04-01Date
Summary
Inhibitor Therapeutics' 8-K filing signals a material development for this biotechnology company, potentially involving clinical trials, partnerships, or financial results. Such disclosures can significantly influence the stock price of small-cap biotech firms.
Actionable: Analyze the filing details for news on drug development milestones or corporate transactions.
AI Confidence: 65%
Data Points
companyInhibitor Therapeutics, Inc. (INTI) (CIK 0001042418)
form8-K
date2026-04-01
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now